These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 22958479)
1. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Mallappa S; Sinha A; Gupta S; Chadwick SJ Colorectal Dis; 2013 Mar; 15(3):323-8. PubMed ID: 22958479 [TBL] [Abstract][Full Text] [Related]
2. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206 [TBL] [Abstract][Full Text] [Related]
3. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer. Shin JS; Suh KW; Oh SY J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893 [TBL] [Abstract][Full Text] [Related]
4. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer. Shibutani M; Maeda K; Nagahara H; Ohtani H; Iseki Y; Ikeya T; Sugano K; Hirakawa K World J Surg Oncol; 2015 Jun; 13():194. PubMed ID: 26040932 [TBL] [Abstract][Full Text] [Related]
6. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma. Sun J; Ning H; Sun J; Qu X Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433 [TBL] [Abstract][Full Text] [Related]
7. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer]. Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414 [TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer. Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis. Li H; Zhao Y; Zheng F Medicine (Baltimore); 2019 Jan; 98(3):e14126. PubMed ID: 30653142 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer. Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672 [TBL] [Abstract][Full Text] [Related]
12. Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer. Jankova L; Dent OF; Chan C; Chapuis P; Clarke SJ BMC Cancer; 2013 Oct; 13():442. PubMed ID: 24079717 [TBL] [Abstract][Full Text] [Related]
13. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer. Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617 [TBL] [Abstract][Full Text] [Related]
14. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Jia J; Zheng X; Chen Y; Wang L; Lin L; Ye X; Chen Y; Chen D; Dettke M Tumour Biol; 2015 Dec; 36(12):9319-25. PubMed ID: 26104767 [TBL] [Abstract][Full Text] [Related]
15. Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer. Hayama T; Hashiguchi Y; Okada Y; Ono K; Nemoto K; Shimada R; Ozawa T; Toyoda T; Tsuchiya T; Iinuma H; Nozawa K; Matsuda K Int J Colorectal Dis; 2020 Jan; 35(1):119-124. PubMed ID: 31797097 [TBL] [Abstract][Full Text] [Related]
16. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Nishiguchi Y; Hirakawa K Anticancer Res; 2013 Aug; 33(8):3291-4. PubMed ID: 23898094 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641 [TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer. Ashizawa N; Furuya S; Katsutoshi S; Sudo M; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D Anticancer Res; 2020 Apr; 40(4):2311-2317. PubMed ID: 32234931 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer. Tohme S; Sukato D; Chalhoub D; McDonald KA; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A Ann Surg Oncol; 2015 May; 22(5):1701-7. PubMed ID: 25190128 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection. Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]